Your Hormones Are Out of Balance. Your Genes May Be Why.

ESR1 encodes the estrogen receptor alpha, the primary protein that sits on your cells and responds to circulating estrogen. Without functional estrogen receptors, estrogen cannot do its job, regardless of how much you produce. This receptor is critical for bone density, cardiovascular health, mood regulation, cognitive function, and menopausal symptom severity.

The PvuII and XbaI variants in ESR1 affect how efficiently the receptor functions and how your cells respond to estrogen signaling. Roughly 40% of the population carries at least one of these variants. If you carry them, your cells may be partially insensitive to estrogen, meaning you need higher levels circulating in your blood to achieve the same biological effect. This can lead to persistent symptoms even when standard hormone tests show ‘normal’ estrogen levels.

You may experience persistent hot flashes or night sweats even during reproductive years, unpredictable mood swings tied to your cycle, lower bone density or osteoporosis despite adequate calcium intake, decreased libido, vaginal dryness, or cardiovascular symptoms that don’t match your risk profile. Men with ESR1 variants may experience reduced bone density, increased fat deposition, or mood changes.

COMT is the enzyme that breaks down dopamine, norepinephrine, and epinephrine. These are your stress hormones and focus chemicals. If your COMT works slowly, these hormones build up in your system. You stay in a low-level fight-or-flight state even when nothing is threatening you. Your nervous system never fully downregulates.

The Val158Met variant is the most studied COMT polymorphism. Roughly 25% of people with European ancestry are homozygous for the slow variant. Slow COMT means you clear stress hormones at 40% the rate of others, leading to chronic sympathetic nervous system activation even during rest. You feel wired, anxious, or overstimulated. Caffeine after noon keeps you awake at 2am. A single stressful email ruins your entire evening.

You probably experience anxiety that doesn’t match your life circumstances, insomnia despite feeling exhausted, emotional sensitivity to criticism or conflict, difficulty downshifting even after work ends, hormonal mood swings that feel disproportionate, or a racing mind at night when you’re trying to sleep.

MTHFR is the enzyme that produces methylfolate, the active form of folate your body uses for hundreds of functions, including thyroid antibody regulation, estrogen metabolism, and neurological function. Methylation is the process by which your body adds methyl groups to hormones and other molecules, making them water-soluble so they can be excreted. Without efficient methylation, hormones recirculate.

The C677T variant, carried by approximately 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70%. This impairs your ability to methylate and clear estrogen, leading to estrogen accumulation and a toxic cycle of re-absorption in the gut. Your estrogen levels stay elevated longer than they should. You experience prolonged PMS symptoms, heavy periods, breast tenderness, water retention, or mood changes that extend through your cycle instead of resolving.

You may also notice hair loss, brain fog, difficulty concentrating, anxiety that worsens in the luteal phase, or fatigue that doesn’t improve with rest. The problem isn’t that you’re not making enough hormones. It’s that you’re not clearing them efficiently.

VDR encodes the vitamin D receptor, the protein that allows your cells to respond to vitamin D. This receptor is critical for immune regulation, hormone metabolism, bone health, and the prevention of autoimmune flare-ups. Vitamin D deficiency is common, but vitamin D resistance due to VDR variants is rarely tested and frequently missed.

The FokI, BsmI, ApaI, and TaqI variants in VDR affect how efficiently the receptor functions. Roughly 30 to 40% of the population carries variants that reduce VDR function. If you have these variants, your cells may not respond normally to vitamin D even if your blood levels are adequate, leaving you functionally deficient at the cellular level. This impairs your immune system’s ability to maintain tolerance and interferes with calcium absorption, bone remodeling, and hormone metabolism.

You may experience autoimmune flare-ups or persistent inflammation despite adequate vitamin D supplementation, weak bones or slow fracture healing, persistent infections or slow immune recovery, muscle weakness or pain, or mood changes that don’t improve despite correcting vitamin D levels on standard testing.

CYP19A1 encodes aromatase, the enzyme that converts testosterone into estrogen. This enzyme is present in both men and women, and it’s critical for maintaining estrogen-to-testosterone balance. If you have high aromatase activity, you’re shunting too much testosterone into estrogen. If aromatase activity is low, testosterone accumulates. Both extremes cause problems.

CYP19A1 variants affect aromatase activity and expression. They’re common in the population. If you have variants that increase aromatase activity, your body preferentially converts testosterone to estrogen, leading to relative testosterone deficiency and estrogen excess, regardless of your actual hormone levels. This creates a state of functional estrogen dominance even if standard tests show normal or low estrogen.

Women may experience PCOS-like symptoms without actually having PCOS (irregular periods, mood changes, stubborn weight gain, difficulty building muscle, hair loss), excess facial or body hair, or enlarged breast tissue. Men may experience reduced muscle mass despite training, low libido, erectile dysfunction, mood changes, or increased fat deposition, especially around the chest and abdomen.

NR3C1 encodes the glucocorticoid receptor, the protein that allows your cells to respond to cortisol. Cortisol is essential for waking you up, managing stress, and regulating immune function and blood sugar. But cortisol resistance is as problematic as cortisol deficiency. If your glucocorticoid receptors don’t function properly, your cells can’t sense cortisol, leading to HPA axis dysregulation and perpetual inflammation.

The BclI and N363S variants in NR3C1 affect glucocorticoid receptor sensitivity and cortisol responsiveness. Roughly 20 to 30% of the population carries these variants. If you have them, your cells may be partially insensitive to cortisol signaling, meaning your HPA axis can’t properly downregulate stress responses and can’t suppress excessive immune activation. You’re stuck in a state of chronic low-grade inflammation and nervous system dysregulation.

You may experience persistent fatigue despite adequate sleep, slow recovery from stress or illness, frequent infections or slow healing, difficulty managing inflammation despite anti-inflammatory interventions, or autoimmune symptoms that flare unpredictably. Your cortisol levels on testing might look normal or high, but your cells aren’t responding appropriately.